Supplier of respiratory diagnosis

Respiratory Test Kits

ABOUT US

Guangzhou Hecin Health Co., Ltd. has China’s largest stock of respiratory virus resources and is able to supply all-inclusive, multi-platform respiratory virus diagnostic products (kits).

We work on the development of diagnosis/treatment products regarding respiratory viruses.China’s top supplier of respiratory diagnosis kits, Covid-19 kits and bio-test agents


Stable Operation

stable operation, mature technology

Quality Guarantee

high-performance, cost-effective

Standard

national standard

Dedication


perience in respiratory test kit

Responsibility


Focus on human respiratory health

Cutting Edge


China’s top developer of respiratory test kit

Authority


A R&D team led by the leading scholar Zhong Nanshan

Product Display

Our diagnostic kits are reliable products developed on the basis of cutting-edge biotechnologies such as flow cytometry, immunofluorescence, immunochromatography and PCR-fluorescent probe technique. They can efficiently detect various respiratory infectious viruses to find out the real pathogen, thereby reducing health risks.

Our Advantages

Our diagnostic kits are reliable products developed on the basis of cutting-edge biotechnologies such as flow cytometry, immunofluorescence, immunochromatography and PCR-fluorescent probe technique. They can efficiently detect various respiratory infectious viruses to find out the real pathogen, thereby reducing health risks.

#

Talent of GRIH

Guangzhou Institute of Respiratory Health (GRIH) has a post-doctoral research station, a national clinical pharmacology base and a special professorship for Pearl River Scholars, with current Director Zhong Nanshan.

#

GMP Workshop

Have a GMP workshop of 2300 square meters, an R&D laboratory of 1600 square meters, a biosafety level 2 (P2) laboratory and a fully automated immunochromatographic reagent production line.

#

Productization

In the face of any public health event, the company is able to quickly apply theoretical findings to research and development and to manufacture the appropriate products using existing production facilities.

#

Code Compliance

Products are developed in such a way that they seek to meet the specifications of the National Medicines and Drug Administration (NMPA), as well as the pharmaceutical regulatory specifications of the EU, FDA and others.

Application

We have the largest respiratory virus resource in China and offer a full range of multi-platform respiratory virus diagnostic products.

Applications of Hecinhealth



his virus reserve contains over 200 strains and over 450 viral strains covering a wide range of common respiratory infection viruses. These include adenovirus, respiratory syncytial, influenza A, influenza B, parainfluenza, parapneumonic and other viruses and their subtypes. The company has established its own virus strain library, which can be used to develop testing reagents and prepare reference products; the company conducts research cooperation projects with organisations such as GRID and the Chinese Academy of Inspection and Quarantine. It also participated in assisting the development of a national reference product for the New Coronavirus during the New Coronavirus outbreak in 2020. Hecin also has a 2300 sqm GMP workshop, a 1600 sqm R&D laboratory area and a biosafety level 2 (P2) laboratory. The fully automated immunochromatographic reagent production line established has an annual capacity of hundreds of millions of servings and has served more than 50 countries and regions worldwide.

Guangzhou Hecin Health Co., Ltd. has China’s largest stock of respiratory virus resources

Is able to supply all-inclusive, multi-platform respiratory virus diagnostic products (kits).